However, IL-18-binding proteins may produce a negative feedback regulation to reduce the production of IL-18 and IFN-γ, which has been confirmed in some preclinical studies, and it may be a new idea in the treatment of SLE (67, 68). The gene discussed is IFNG; the disease is systemic lupus erythematosus.